Enzyme Replacement Therapy (ERT): Clinical Trials

2 trials of Enzyme Replacement Therapy (ERT), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Enzyme Replacement Therapy (ERT): new trials by email Literature Review of Enzyme Replacement Therapy (ERT) trials Research Report on Enzyme Replacement Therapy (ERT)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.
Enzyme Replacement Therapy (ERT) - Fabry Disease
CompletedAmicus Therapeutics822020-03-012026-02-05
A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease
Lucerastat, Enzyme replacement therapy (ERT) - Fabry Disease
Phase 1CompletedIdorsia Pharmaceuticals Ltd.142015-02-012018-07-10

Conditions studied

Fabry Disease (2)

Sponsors

Amicus Therapeutics (1)  ·  Idorsia Pharmaceuticals Ltd. (1)

Countries

Brazil (1)  ·  Germany (1)  ·  Japan (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Results publications

PMID 28088251, PMID 40790487